Placebos, active control groups, and the unpredictability paradox

Biological Psychiatry

Volumn 47, Issue 8, 2000, Pages 693-698

  Mattocks, Kristin M ^a   Horwitz, Ralph I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Active control groups; Placebos; Randomized controlled trials

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; LIDOCAINE; NITRATE; NITROPRUSSIDE SODIUM; PLACEBO; SULFINPYRAZONE;

ANGINA PECTORIS; CARDIOLOGY; CLINICAL TRIAL; COMORBIDITY; CONTROL; CONTROLLED CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; ETHICS; HEART INFARCTION; HUMAN; MEDICAL RESEARCH; PREDICTION; PRIORITY JOURNAL; PSYCHIATRY; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; STROKE; VEIN THROMBOSIS;

EID: 0034655570     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00839-8     Document Type: Review

References (22)

1. A randomized trial of propranolol in patients with acute myocardial infarction. N Engl J Med. 311:1984;552-559.
2. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med. 303:1980;1038-1041.
3. Haynes R.B., Taylor D.W., Sackett D.L. Compliance in Health Care. 1979;Johns Hopkins University Press, Baltimore.
4. Horwitz R.I. Complexity and contradiction in clinical trial research. Am J Med. 82:1987;498-510.
5. Horwitz R.I., Horwitz S.M. Adherence to treatment and health outcomes. Arch Intern Med. 153:1993;1863-1868.
6. Horwitz R.I., Singer B.H., Makuch R.W., Viscoli C.M. Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. J Clin Epidemiol. 49:1996;395-400.
7. Kernan W.N., Horwitz R.I., Brass L.M., Viscoli C.M., Taylor K.J. A prognostic system for transient ischemia or minor stroke. Ann Intern Med. 114:1991;552-557.
8. Kienle G.S., Kiene H. The powerful placebo effect Fact or fiction? J Clin Epidemiol. 50:1997;1311-1318.
9. Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol. 16:1985;1189-1202.
10. Kunz R., Oxman A. The unpredictability paradox Review of empirical comparisons of randomised and non-randomised clinical trials . BMJ. 317:1998;1185-1190.
11. Levine J.D., Gordon N.C., Fields H.L. The mechanism of placebo analgesia. Lancet. 3:1978;654-657.
12. Lima MS, Moncrieffe J (1999): Drugs versus placebo for the treatment of dysthymia (Cochrane Review). The Cochrane Library Issue 3.
13. McDonald C.J., Mazzuca S.A. How much of the placebo "effect" is really statistical regression? Stat Med. 2:1983;417-427.
14. Nomenclature and Criteria for Diagnosis of Disease of the Heart and Great Vessels. 9th ed. 1994;Little Brown, Boston.
15. Rekha G., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 273:1995;1450-1456.
16. Shapiro A.K. The Powerful Placebo From Ancient Priest to Modern Physician . 1997;Johns Hopkins University Press, Baltimore.
17. Sobin L.H., Wittekind C. TNM Classification of Malignant Tumors. 5th ed. 1997;Wiley-Liss, New York.
18. Sutherland L.R., May G.R., Shaffer E.A. Sulfasalazine revisited A meta-analysis of 5-aminosalicyclic acid in the treatment of ulcerative colitis . Ann Intern Med. 118:1993;540-549.
19. Temple R.J. When are clinical trials of a given agent vs. placebo no longer appropriate or feasible? Control Clin Trials. 18:1997;613-620.
20. Thase M.E. How should efficacy be evaluated in randomized clinical trials of treatments for depression? J Clin Psychiatry. 60:1999;23-31.
21. Wickramasekera I (1985): A conditioned response model of the placebo effect: Predictions from the model. In: White L, Tursky B, Schwartz GE, editors. Placebo - Theory, Research, and Mechanisms. New York: Guilford, 255-287.
22. Declaration of Helsinki. 1964;World Health Organization, Geneva.